
CS-O-00218 ·
Clearsynth · Cat: CS-O-00218
Reach 3+ verified distributors
Manufacturer product page
clearsynth.com/product/CS-O-00218
Description
Dolutegravir is a second generation HIV1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peri

